MEDICAMEN BIOTECH
Back to Cashflow Statement
|
MEDICAMEN BIOTECH Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹-6.29 Cr | ₹4.11 Cr | ₹13 Cr | ₹13 Cr | ₹4.30 Cr |
What is the latest Cash Flow from Operating Activities ratio of MEDICAMEN BIOTECH ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2023 | ₹-6.29 Cr |
Mar2022 | ₹4.11 Cr |
Mar2021 | ₹13 Cr |
Mar2020 | ₹13 Cr |
Mar2019 | ₹4.30 Cr |
How is Cash Flow from Operating Activities of MEDICAMEN BIOTECH Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2023 | ₹-6.29 Cr | Negative | |
Mar2022 | ₹4.11 Cr | -67.83 | |
Mar2021 | ₹13 Cr | -0.23 | |
Mar2020 | ₹13 Cr | 197.65 | |
Mar2019 | ₹4.30 Cr | - |
Compare Cash Flow from Operating Activities of peers of MEDICAMEN BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MEDICAMEN BIOTECH | ₹681.9 Cr | 7.5% | 29.9% | -19.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,290.0 Cr | -0.9% | 0.9% | 62.6% | Stock Analytics | |
CIPLA | ₹113,357.0 Cr | 3.5% | 4.2% | 51.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹111,134.0 Cr | 12.2% | 18% | 103.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,235.0 Cr | 0.8% | 5.6% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,001.5 Cr | -1% | -2.4% | 28.4% | Stock Analytics |
MEDICAMEN BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MEDICAMEN BIOTECH | 7.5% |
29.9% |
-19.5% |
SENSEX | 1.7% |
1.5% |
18.7% |
You may also like the below Video Courses